Similar to this, Komohara et al. showed that CD204+ tumor-associated macrophages and tumor cells in patients with clear cell renal cell carcinoma expressed TIM-3 strongly and that a higher level of TIM-3 expression was positively correlated with shorter progression-free survival in these patients [14]. This evidence concerns the gene HAVCR2 and neoplasm.